1 / 10

Featured Article :

Featured Article :. IRS1 Genotype Modulates Metabolic Syndrome Reversion in Response to 2-Year Weight-Loss Diet Intervention The POUNDS LOST trial.

adonica
Download Presentation

Featured Article :

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Featured Article: IRS1 Genotype Modulates Metabolic Syndrome Reversion in Response to 2-Year Weight-Loss Diet Intervention The POUNDS LOST trial Qibin Qi, P.H.D., Min Xu, M.D., P.H.D., Hongyu Wu, P.H.D., Liming Liang, P.H.D., Catherine M. Champagne, P.H.D., George A. Bray, M.D., Frank M. Sacks, M.D., Lu Qi, M.D., P.H.D. Diabetes Care Volume 36: 3442-3447 November, 2013

  2. STUDY OBJECTIVE • Genetic variants near IRS1 are associated with features of the metabolic syndrome (MetS) • We examined whether genetic variants near IRS1 might modulate the effects of diets varying in fat content on the MetS status in a 2-year weight-loss trial Qi Q. et al. Diabetes Care 2013;36:3442-3447

  3. STUDY DESIGN AND METHODS • Two variants near IRS1 (rs1522813 and rs2943641) were genotyped in 738 overweight/obese adults randomly assigned to one of four weight-loss diets • Diets varied in macronutrient content and lasted for 2 years • MetS status of high-fat (40% caloric intake) and low-fat (20% caloric intake) diet groups differentiated by genotypes was compared (rs1522813 A-allele carriers and noncarriers and rs2943641T-allele carriers and noncarriers) Qi Q. et al. Diabetes Care 2013;36:3442-3447

  4. RESULTS • Among rs1522813 A-allele carriers, reversion rates of MetS were higher in the high-fat diet group than in the low-fat diet group • No significant difference between diet groups was observed among noncarriers • Genetic modulation on dietary effect was independent of weight changes Qi Q. et al. Diabetes Care 2013;36:3442-3447

  5. RESULTS • Odds ratio (OR) for the 2-year reversion of the MetS was 2.88, comparing the high-fat and low-fat diets among rs1522813 A-allele carriers • Corresponding OR was 0.83 in noncarriers • rs2943641 was not observed to modulate dietary effects on the MetS status Qi Q. et al. Diabetes Care 2013;36:3442-3447

  6. Qi Q. et al. Diabetes Care 2013;36:3442-3447

  7. CONCLUSIONS • High-fat weight-loss diets might be more effective in the management of the MetS compared with low-fat diets among individuals with the A-allele of the rs1522813 variant near IRS1 Qi Q. et al. Diabetes Care 2013;36:3442-3447

  8. Qi Q. et al. Diabetes Care 2013;36:3442-3447

  9. Qi Q. et al. Diabetes Care 2013;36:3442-3447

  10. Qi Q. et al. Diabetes Care 2013;36:3442-3447

More Related